P-1726. Mucormycosis coinfection by plasma Mucorales PCR in patients with proven aspergillosis

Abstract Background Diagnosis of mucormycosis is challenging due to lack of antigen testing and low sensitivity of fungal culture, especially when biopsy is not feasible. There are limited data on coinfection of Aspergillus and Mucorales, although identifying coinfection is important for management. Thus, we systematically investigated mucormycosis coinfection in proven or probable aspergillosis, using plasma Mucorales PCR.Table.Diagnostic characteristics of the study participants Methods The medical records of adult patients with proven and probable aspergillosis were retrospectively reviewed at a tertiary hospital during Jan 2017 to Apr l 2020 and Jun 2023- Feb 2025. The fungal culture results were reviewed. The plasma 18S PCR was performed to detect Aspergillus- and Mucorales-specific DNA. Results A total of 85 patients with proven 29 and probable 56 aspergillosis were analyzed. No Mucorales was found in sterile and non-sterile cultures. In 29 patients with proven aspergillosis, a positive Mucorales-specific PCR result was obtained for 2 patients (6.9%) while positive Aspergillus- and Mucorales-specific PCR results were obtained for 2 patients (6.9%). In proven aspergillosis, 13.8% (4/29) showed evidence of mucormycosis coinfection. In 56 patients with probable aspergillosis, a positive Mucorales-specific PCR result was obtained for 7 patients (12.5%) while positive Aspergillus- and Mucorales-specific PCR results were obtained for 5 patients (8.9%). In probable aspergillosis, 21.4% (12/56) showed evidence of mucormycosis coinfection. Overall, 16 (18.8%) of the 85 patients with proven or probable aspergillosis showed evidence of mucormycosis coinfection. In hospital mortality did not differ between patients with mucormycosis coinfection who was treated with voriconazole and those with aspergillosis alone with voriconazole (38.5% [5/13] vs 29.4% [15/51]; p 0.52). Conclusion About 15-20% of patients with proven or probable aspergillosis had molecular evidence of mucormycosis coinfection by plasma Mucorales PCR. Further studies are needed. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.1897
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-1726. Mucormycosis coinfection by plasma Mucorales PCR in patients with proven aspergillosis

Sung-Han Kim, Ji Yeon Kim, Hyeonji Seo, Hyeon Mu Jang
Open Forum Infectious Diseases
Antifungal resistance and susceptibility
article

P-1726. Mucormycosis coinfection by plasma Mucorales PCR in patients with proven aspergillosis

Sung-Han Kim, Ji Yeon Kim, Hyeonji Seo, Hyeon Mu Jang
article en

Abstract

Abstract Background Diagnosis of mucormycosis is challenging due to lack of antigen testing and low sensitivity of fungal culture, especially when biopsy is not feasible. There are limited data on coinfection of Aspergillus and Mucorales, although identifying coinfection is important for management. Thus, we systematically investigated mucormycosis coinfection in proven or probable aspergillosis, using plasma Mucorales PCR.Table.Diagnostic characteristics of the study participants Methods The medical records of adult patients with proven and probable aspergillosis were retrospectively reviewed at a tertiary hospital during Jan 2017 to Apr l 2020 and Jun 2023- Feb 2025. The fungal culture results were reviewed. The plasma 18S PCR was performed to detect Aspergillus- and Mucorales-specific DNA. Results A total of 85 patients with proven 29 and probable 56 aspergillosis were analyzed. No Mucorales was found in sterile and non-sterile cultures. In 29 patients with proven aspergillosis, a positive Mucorales-specific PCR result was obtained for 2 patients (6.9%) while positive Aspergillus- and Mucorales-specific PCR results were obtained for 2 patients (6.9%). In proven aspergillosis, 13.8% (4/29) showed evidence of mucormycosis coinfection. In 56 patients with probable aspergillosis, a positive Mucorales-specific PCR result was obtained for 7 patients (12.5%) while positive Aspergillus- and Mucorales-specific PCR results were obtained for 5 patients (8.9%). In probable aspergillosis, 21.4% (12/56) showed evidence of mucormycosis coinfection. Overall, 16 (18.8%) of the 85 patients with proven or probable aspergillosis showed evidence of mucormycosis coinfection. In hospital mortality did not differ between patients with mucormycosis coinfection who was treated with voriconazole and those with aspergillosis alone with voriconazole (38.5% [5/13] vs 29.4% [15/51]; p 0.52). Conclusion About 15-20% of patients with proven or probable aspergillosis had molecular evidence of mucormycosis coinfection by plasma Mucorales PCR. Further studies are needed. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 13(Supplement_1)
Asan Medical Center (KR)
Openalex Percentile: Top 91%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

P-1726. Mucormycosis coinfection by plasma Mucorales PCR in patients with proven aspergillosis — Sung-Han Kim, Ji Yeon Kim, et al. · Open Forum Infectious Diseases (2026) | TGRS Research Map | TGRS